Skip to content
Topics/Cardiovascular

Atrial fibrillation

Pro
Audio podcast
Listen on the go — with live captions.
Infographic
High-yield one-pager.
Slide deck
Tight, illustrated review.
MCQs
10 questions available
Easy · 2
Medium · 5
Hard · 3

Case simulations

Learn this topic by working through ED cases step-by-step.

medium
~15 min
Pro
65F with Palpitations and Hypotension

A 65-year-old female presents with rapid palpitations, altered mental status, and severe hypotension.

easy
~15 min
Pro
22F with Holiday Heart Syndrome

A 22-year-old female presents with palpitations and mild dyspnea after heavy weekend binge drinking.

hard
~15 min
Pro
28M with Wide-Complex Irregular Tachycardia

A 28-year-old male with a known history of WPW presents with an irregular, polymorphic wide-complex tachycardia.

Mind map

Summary

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

Atrial fibrillation (AFib) is characterized by the loss of organized atrial contraction, replaced by rapid, chaotic electrical activity. This uncoordinated firing bombards the atrioventricular (AV) node, which acts as a gatekeeper, resulting in the hallmark irregularly irregular ventricular response.

At the mechanical level, the loss of organized atrial depolarization abolishes the "atrial kick," which normally contributes up to 20-30% of ventricular end-diastolic volume (preload). This sudden loss of preload, combined with a rapid ventricular rate that drastically shortens diastolic filling time, can severely compromise stroke volume and cardiac output. This physiology is particularly catastrophic in patients with stiff, non-compliant ventricles or stenotic valves (e.g., mitral stenosis), precipitating acute heart failure or cardiogenic shock. Concurrently, the mechanical stasis of blood in the fibrillating atria predisposes the patient to thrombus formation and subsequent devastating arterial embolization (stroke).

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

  • Immediate Stabilization: Assess the ABCs, place the patient on continuous cardiopulmonary monitoring, establish large-bore IV access, and obtain a 12-lead ECG.
  • Determine Stability: You must immediately determine if the patient has cardiopulmonary compromise caused by the dysrhythmia. Instability is strictly defined by the presence of hypotension, acutely altered mental status, signs of shock, ischemic chest discomfort, or acute heart failure.
  • The Unstable Pathway:
  • Perform immediate Synchronized Cardioversion.
  • Critical Update: Based on current AHA ACLS guidelines, utilize a higher initial energy setting of $\ge$200 Joules for the first shock in Atrial Fibrillation and Atrial Flutter to maximize first-shock success. Provide procedural sedation if feasible.
  • The Stable Pathway (Rate Control):
  • Administer Diltiazem 15 to 20 mg IV bolus over 2 minutes.
  • If the rate response is inadequate, repeat the bolus. Once satisfactory rate control is achieved, initiate a continuous IV infusion at 5 to 10 mg/h, titrating to a ventricular rate of <90 to 100 beats/min. Metoprolol is a viable beta-blocker alternative.
  • Rhythm Conversion & Anticoagulation: If the onset of symptoms is definitively <48 hours, cardioversion (chemical or electrical) may be considered. If >48 hours or unknown, do not cardiovert in the ED; the patient requires 3 weeks of systemic anticoagulation first.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

  • "Can't-Miss" Differential Diagnoses:
  • Pre-excited Atrial Fibrillation (AFib with WPW): Presents as a highly irregular, wide-complex tachycardia that can easily degenerate into ventricular fibrillation if mismanaged.
  • Multifocal Atrial Tachycardia (MAT): An irregular rhythm with at least three distinct P-wave morphologies, classically seen in severe COPD exacerbations or sepsis.
  • Atrial Flutter with Variable Block: Can perfectly mimic the irregular rate of AFib but is driven by a macro-reentrant circuit.
  • Thyroid Storm / Thyrotoxicosis: Can present with isolated new-onset AFib and tachycardia out of proportion to fever.
  • Prioritized Diagnostic Workup:
  • 12-Lead ECG: The gold standard for rhythm identification and to measure QRS duration.
  • Laboratory Panel: Basic metabolic panel, magnesium, CBC, and crucially, Thyroid Function Tests (TSH) for any new-onset AFib. Obtain a PT/INR if the patient is on warfarin.
  • Biomarkers: Serial high-sensitivity troponins to assess for demand ischemia or primary ACS, and BNP to evaluate for concurrent heart failure.
  • Imaging: Portable chest radiograph to evaluate for pulmonary edema, cardiomegaly, or occult pneumonia.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

  • The 12-Lead ECG: Scrutinize the strip for an "irregularly irregular" RR interval and the absolute absence of distinct, organized P-waves. Actively look for the Ashman phenomenon: an aberrantly conducted wide QRS complex that classically occurs following a long-short cardiac cycle. If the QRS is wide ($\ge$0.12 seconds), you must evaluate for a bundle branch block or WPW.
  • Point-of-Care Ultrasound (POCUS): Perform a rapid bedside echocardiogram to evaluate left ventricular contractility and identify structural heart disease (e.g., mitral stenosis, hypertrophic cardiomyopathy). Assess the lungs for B-lines indicating acute pulmonary edema.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

  • CHA2DS2-VASc Score: The validated clinical tool used to risk-stratify the potential for future arterial embolic complications and stroke. A score of 0 or 1 identifies a low-risk patient who may not require long-term anticoagulation.
  • CHADS2 Score: An older, simpler iteration of stroke risk stratification still referenced in clinical practice.
  • HAS-BLED Score: A validated scoring system (Hypertension, Abnormal renal/liver function, Stroke, Bleeding history, Labile INR, Elderly, Drugs/alcohol) used to predict bleeding risk in patients being considered for systemic anticoagulation.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

  • Cognitive Trap (Cardioverting the Unknown): Attempting chemical or electrical cardioversion on a stable patient whose AFib onset is unknown or >48 hours. Correction: This carries a massive risk of precipitating an embolic stroke. These patients must be rate-controlled and anticoagulated for 3 weeks prior to cardioversion.
  • Cognitive Trap (AV Nodal Blockers in WPW): Administering AV nodal blocking agents (Diltiazem, Metoprolol, Adenosine) to a patient with a wide-complex, irregularly irregular tachycardia (AFib with WPW). Correction: Blocking the AV node eliminates the natural bottleneck, forcing all atrial impulses down the accessory pathway, rapidly precipitating ventricular fibrillation and death. Use synchronized cardioversion or Procainamide instead.
  • Critical Action (Treat the Patient, Not the Monitor): Do not aggressively rate-control a compensatory tachycardia. If the patient is septic, hypovolemic, or bleeding, the rapid AFib may be maintaining their cardiac output. Treat the underlying shock state first.

7. MCQ MASTERCLASS (Written Exam Tips)

  • Buzzwords: "Irregularly irregular," "Holiday heart syndrome" (acute ethanol intoxication causing transient AFib), "Ashman phenomenon" (wide complex following a long-short cycle).
  • The "Structural" Distractor: A 32-year-old woman presents with AFib, pulmonary edema, and a diastolic murmur at the apex. A distractor option will suggest giving a $\beta$-agonist to increase chronotropy. Explanation: The murmur indicates mitral stenosis. Tachycardia is lethal here because it drastically shortens diastolic filling time across the tight valve. The correct answer is a beta-blocker to achieve a "slow and full" state.
  • The "Binge Drinking" Presentation: A healthy 22-year-old female presents with palpitations and an irregularly irregular narrow-complex tachycardia at 170 bpm after a weekend of heavy alcohol use. Explanation: This is classic "Holiday Heart." The correct management is rate control (e.g., with a calcium channel blocker) and observation, as it is often self-limiting.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

  • The Initial Approach: "This patient is presenting with a rapid, irregularly irregular rhythm on the monitor. I will immediately assess their ABCs, establish large-bore IV access, apply supplemental oxygen if hypoxic, and order a stat 12-lead ECG to confirm atrial fibrillation and measure the QRS duration."
  • Assessing Stability: "I am explicitly evaluating the patient for signs of cardiopulmonary compromise, specifically hypotension, altered mental status, or ischemic chest pain. If the patient is unstable, I will immediately perform synchronized electrical cardioversion starting at 200 Joules, utilizing procedural sedation if time permits."
  • Stable Management & Disposition: "Because the patient is hemodynamically stable and the QRS is narrow, my primary goal is rate control. I am ordering a Diltiazem 20 mg IV bolus. I will calculate their CHA2DS2-VASc score to determine stroke risk. Since their symptom onset is clearly greater than 48 hours, I will not attempt rhythm conversion today in the ED to avoid an embolic event, and I will arrange for appropriate outpatient cardiology follow-up."